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Objectives: The aim of this study was to investigate the incidence of different
pathogens responsible for respiratory tract infections in adult patients with cystic
ﬁbrosis (CF) followed up in our department, through 2002–2009.
Patients-methods: Data from 40 patients with CF (mean age 30.7±2.2, SS 71±8),
were analyzed. 620 sputum samples were cultured for common pathogens and
a growth of >106 cfu was considered as positive. Vitek2 system was used to
identiﬁcate bacterial strains and detect MIC and FISH method was used to screen
samples for B. cepacia. As chronic colonization with Pseudomonas aeruginosa was
deﬁned patients with at least 3 positive cultures for a 6-month period and increased
antipseudomonal antibodies levels (measured by serum ELISA method).
Results: The commonest isolate was Pseudomonas aeruginosa (68%) with resis-
tance to tobramycin and ciproﬂoxacin 58% and 50% respectively in 2009, followed
by S. aureus (12.5%) and H. inﬂuenzae (8.8%). Most P. aeruginosa strains were
of mucoid phenotype (80%). There is an increasing rate up for A. xylosoxidans,
mainly in patients without Pseudomonas chronic colonization. No B. cepacia was
detected in any sample.
Conclusion: The microbiological data of respiratory infections in CF patients
followed up at our center are generally according to literature. There is an increasing
incidence of A. xylosoxidans the last years. The increasing rate of P. aeruginosa
resistance to tobramycin and ciproﬂoxin is alarming for appropriate use of antimi-
crobials as well as for a numerous interconnected factors that encouraged the spread
of resistance. The absence of B. cepacia is hopeful for the evolution of our patients.
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Background: Changing microbiology patterns in Australian adults with CF is not
well understood.
Aim: To determine the annual prevalence of microbial pathogens infecting the lungs
of patients attending TPCH Adult CF Centre.
Method: A retrospective review of all expectorated sputum cultures collected from
2001 to 2008 was undertaken.
Results: Over the eight year period a total of 339 adult CF patients (female
42.7%) were treated at TPCH. The most prevalent bacterial pathogen encountered
was Pseudomonas aeruginosa (Pa) [74.0%], and this decreased by ~1% per year.
Conversely, the rate of patients remaining free of Pa infection increased from 18.2%
to 27.0%. Methicillin sensitive Staphylococcus aureus was detected in 38% of
patients and remained stable over time. Fungal infection with Aspergillus spp. was
common and decreased by 9% over the eight years. Stenotrophomonas maltophilia
and Achromobacter xylosoxidans infections were detected in less than 10% of
patients. The prevalence of MRSA decreased over the study period (9.3% to 3.4%).
The mean number of sputum samples collected decreased from 7.5/patient/year to
5.0/patient/year. The proportion of patients who submitted 1 sputum sample was
similar each year. In 2008, 72.2% of patients had 2 and 52.9% had 4 sputum
samples submitted.
Conclusion: The most prevalent organism in this large adult CF setting was Pa.
Decreasing rates of Pa and MRSA were observed over the study period. The
percentage of adults with 1 respiratory sample collected for culture per year
is below that reported in the USA, but many of these patients were non-sputum
producers or rarely attended the clinic.
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Background: Dynamics of bacterial colonization in cystic ﬁbrosis (CF) patients
might have change over the last years. Patters of respiratory bacterial colonization
from two different follow-up periods were compared: 1995−97 vs. 2006−08.
Material and Methods: We compare two different stages: period A (1995–1997)
including 81 patients and period B (2006–2008) with 127 patients. Clinical and mi-
crobiological results were retrospectively recovered, focusing in bacterial pathogens,
and taking account all respiratory follow-up samples. To better understand the
pulmonary colonization, different age-segments were contemplated, as well as three
categories: non-colonized, colonized/infected intermittently, and colonized/infected
chronically.
Results: S. pneumoniae and H. inﬂuenzae was only observed in the early ages. The
most frequent pathogens detected in both A and B periods were P. aeruginosa (69%
and 52%) and S. aureus (75% and 58%), respectively. In the period B colonization
by pathogens was retarded. Coexistence of several pathogens was a common feature
in both stages, ﬁnding only differences for S. aureus + H. inﬂuenzae, which
increased signiﬁcantly from 5% in the ﬁrst period A to 27% in the second one.
Approximately the half of the 35 years patients in the period B were classiﬁed as
non-infected, whereas in the period A all of them were colonizer/infected at least
by P. aeruginosa.
Conclusions: Patters of bacterial bronchopulmonary colonization have change in
our patients over the last decade, with a decrease in P. aeruginosa and S. aureus
colonization and early acquisition of these pathogens. Introduction of inhaled
therapy might have contributed to these results.
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The microbiology of the CF lung has been extensively studied over recent years
using both culture dependent and independent techniques. This has been predomi-
nantly limited to the bacteria.
Aim: To comprehensively study the metabolically active lung microbiota in CF
including fungi, archaea and bacteria for the ﬁrst time, in order to see which
organisms co-exist in these complex communities.
Methods: Thirty adult CF patients were recruited at our CF Centre and sponta-
neously expectorated sputum samples were collected when clinically stable. RNA
was extracted from the samples and RT-PCR-DGGE was used to analyse the
bacterial, fungal and archaeal communities using universal primer sets.
Results: The bacterial community present in CF patients is the most diverse group
with archaea and fungi considerably less diverse.
Conclusions: An array of bacteria, fungi and archaea are able to colonise the CF
lung at any one time and therefore further study is required to elucidate the complex
interactions between these organisms. Our longitudinal studies of this nature may
deﬁne what the causative organisms in acute pulmonary exacerbations and help
with more tailored antibiotic therapy.
